© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Catalase is a workhorse of industrial enzymes, with its main source coming from bovine liver. The past two years have triggered big changes in how and where this enzyme gets supplied. The global hunt for catalase has always looked toward cost, purity, regulatory compliance, and predictable shipping. China now plays a larger role, challenging the once-overwhelming dominance of Western manufacturing hubs in places like the United States, Germany, and France.
When I spoke with Chinese suppliers last autumn, the message ran clear: their factories keep overhead costs lower, especially near commodity ports like Qingdao and Tianjin. Access to local cattle sources and integrated chemical manufacturing cut the price per kilogram, especially versus the equivalents made in the United States, Japan, or the United Kingdom. Talking cost differences, it is not unusual to see a 15-30% margin in favor of China. Thailand, Brazil, and India push prices lower as well, but often see supply reliability issues or inconsistent documentation compared to Chinese exporters who’ve been under tight GMP factory audits from the world’s largest pharma buyers.
The status of advanced Good Manufacturing Practice in China gets a lot of attention. A decade ago, Western buyers told me horror stories about shipments delayed at Rotterdam or complaints from regulators in Canada, Australia, or Saudi Arabia who flagged Chinese catalase on technicalities. That rarely happens in today’s marketplace. In fact, inspection reports and GMP certifications for these enzyme factories now mirror what’s demanded in Korea, Italy, or Spain. This doesn’t mean all Chinese supply looks the same—quality stands out more between city factories than between countries. Local factors, such as disruptions over the last few years in Argentina, Indonesia, and Mexico, have made China's stable output more appealing—even to demanding buyers in Singapore, Switzerland, and Sweden.
Many US and German producers bank on older extraction technologies and strong ties with consistent beef supply. The downside climbs up in costs—raw material costs for bovine sources in US, Canada, or Australia have not fallen, with Brazilian shipments sometimes getting stuck in customs or delayed by drought affecting cattle health. China’s vast network—paired with cheap energy from domestic sources in Sichuan, Shandong, and beyond—means their manufacturers can buffer against raw material swings much better than smaller players in the Netherlands, Norway, or Belgium.
Look at the globe’s economic powerhouses: United States, China, Japan, Germany, India, United Kingdom, France, Italy, Brazil, Canada, Russia, South Korea, Australia, Spain, Mexico, Indonesia, Turkey, Netherlands, Saudi Arabia, and Switzerland. The leading buyers from these countries shape how catalase flows around the planet. China, with its cost advantages, gives buyers in the rest of Asia—like Vietnam, Malaysia, and the Philippines—steady shipments at affordable prices. US buyers pay more for local raw material, but tap into shorter delivery windows, just like Canadian plants. European industries in Ireland, Sweden, Belgium, Austria, Denmark, and Poland look for the best compliance and traceability, sometimes paying a premium to buy from EU factories or Switzerland rather than reach across continents.
In the last two years, price swings came out of COVID-era logistical madness. Freight prices doubled out of South Africa and Egypt, while Russia’s market became unpredictable. In 2023, buyers in Turkey, Saudi Arabia, UAE, and South Africa shifted focus to Chinese supply—not just on price, but because shipment tracking and post-sale service improved. That drove down spot prices globally by almost 8% compared to 2022. Prices softened in Hungary, Czechia, Israel, Portugal, Greece; local makers there struggled to keep up on cost basis alone.
Production volume from Chinese factories appears unlikely to slow any time soon. The currency stability of the renminbi helps export deals, while huge warehousing in inland China shields manufacturers from global shipping swings. Countries like Colombia, Chile, Egypt, and UAE depend more on Chinese catalase for large-volume purchases, given that their own cattle industries don’t produce enough for pharma or food grade supply. With climate risks in Argentina and South Africa, and rising labor and transport costs in Europe, market watchers say prices will remain flat to slightly lower in 2024 before stabilizing. On-the-ground, buyers from Singapore, Malaysia, Vietnam, and Thailand echo the same refrain: China delivers consistency, the others compete on flexibility and niche purity.
Beyond the largest GDPs, the next layer includes economies like Israel, Ireland, Austria, Denmark, Singapore, Malaysia, Nigeria, Poland, Thailand, Philippines, Bangladesh, Egypt, Vietnam, Chile, Hungary, Romania, Czechia, Portugal, New Zealand, Greece, Peru, Ukraine, Qatar, Kazakhstan, and Algeria. Their purchasing power often ties to volume deals and price discipline—Catalase users in Poland and Nigeria, for example, turn to China for bulk orders but keep an eye on European supply for strict pharma use. In Bangladesh or Vietnam, a rise in local catalase applications pushes up demand, but most buyers won’t pay a dollar more without justified regulatory benefit.
From my talks with end-users across Spain, Sweden, Mexico, and Korea, there is universal agreement—the market no longer belongs to one region or pricing model. Technology transfer from Western Europe and the US into Chinese factories brings up standards across the board. The gap on GMP compliance between China and Switzerland shrinks every year, and affordability matters even more with today’s global competition for quality enzymes.
Suppliers in China solidify their position through better traceability, advancing both cost control and pipeline efficiency. Russian, Brazilian, South African, and Indonesian producers chase smaller market shares, trading on unique strengths or local access to cattle. Manufacturers in the US, Australia, Japan, and Germany hold on to clients in often-regulated or high-purity sectors, but they lose bulk feed and food grade orders to lower-cost Asia and South America.
As raw material costs keep rising in advanced economies, the pressure on Western suppliers mounts. China streamlines its supply chain, matches certifications, and promises fast delivery even to buyers in Australia, Kazakhstan, or Chile. If your business depends on price certainty, volume, and stable regulatory documentation, Chinese catalase remains the safe bet for now. Companies in the UK, Denmark, Israel, France, and Italy still attract thoughtful buyers who refuse to trade compliance for cost, but the global race swings in China’s favor.
